Background Prostate cancer remains the most common non-skin cancer malignancy in men.
Prostate-specific antigen (PSA) is recognized as a biomarker for the diagnosis, monitoring …

The early and accurate detection of prostate cancer is important to ensure timely
management and appropriate individualized treatment. Currently, conventional imaging has …

Background Although prostate‐specific antigen (PSA) testing is used for prostate cancer
detection and posttreatment surveillance, thresholds in these settings differ. The screening …

Objective To examine follow‐up procedures after men are discharged into primary care
following prostate cancer and highlight any areas for service improvement. Methods Patient …

The article focuses on the working of the organization Young Urology Researchers
Organisation (YURO). It mentions the benefits of open access and lateral sharing of …

Patients who receive a diagnosis of metastatic castration-sensitive prostate cancer (CSPC)
have different phenotypes of disease. Some of them have de novo CSPC, but others receive …

Objectives: The aim of this study was to compare prostate-specific antigen (PSA) kinetics–
half-life time (HT), doubling time (DT), and elimination rate PSA (ePSA) in prostate cancer …

Objective: This study “Profiling of SDS-PAGE based differentially expressed proteins from
sera of patients with prostate carcinoma” provides an update on the novel candidate …

AIM To systematically review the measurement properties of instruments assessing
participation in young people with autism spectrum disorder (ASD). METHOD A search was …

abstract The early and accurate detection of prostate cancer is important to ensure timely
management and appropriate individualized treatment. Currently, conventional imaging has …